182 related articles for article (PubMed ID: 36185581)
1. Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening.
Andersson J; Palsdottir T; Lantz A; Aly M; Grönberg H; Egevad L; Eklund M; Nordström T
Eur Urol Open Sci; 2022 Oct; 44():69-75. PubMed ID: 36185581
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.
Grönberg H; Eklund M; Picker W; Aly M; Jäderling F; Adolfsson J; Landquist M; Haug ES; Ström P; Carlsson S; Nordström T
Eur Urol; 2018 Dec; 74(6):722-728. PubMed ID: 30001824
[TBL] [Abstract][Full Text] [Related]
4. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
[TBL] [Abstract][Full Text] [Related]
5. Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms.
Nordström T; Engel JC; Bergman M; Egevad L; Aly M; Eklund M; Palsdottir T; Grönberg H
Eur Urol Open Sci; 2021 Feb; 24():11-16. PubMed ID: 34337490
[TBL] [Abstract][Full Text] [Related]
6. Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.
Björnebo L; Discacciati A; Falagario U; Vigneswaran HT; Jäderling F; Grönberg H; Eklund M; Nordström T; Lantz A
JAMA Netw Open; 2024 Apr; 7(4):e247131. PubMed ID: 38648061
[TBL] [Abstract][Full Text] [Related]
7. External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort.
Palsdottir T; Grönberg H; Hilmisson A; Eklund M; Nordström T; Vigneswaran HT
Eur Urol Focus; 2023 May; 9(3):455-462. PubMed ID: 36522257
[TBL] [Abstract][Full Text] [Related]
8. Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.
Krilaviciute A; Becker N; Lakes J; Radtke JP; Kuczyk M; Peters I; Harke NN; Debus J; Koerber SA; Herkommer K; Gschwend JE; Meissner VH; Benner A; Seibold P; Kristiansen G; Hadaschik B; Arsov C; Schimmöller L; Giesel FL; Antoch G; Makowski M; Wacker F; Schlemmer HP; Kaaks R; Albers P
Eur Urol Oncol; 2023 Dec; 6(6):566-573. PubMed ID: 37806841
[TBL] [Abstract][Full Text] [Related]
9. A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening Study.
Waldén M; Aldrimer M; Lagerlöf JH; Eklund M; Grönberg H; Nordström T; Palsdottir T
Eur Urol Open Sci; 2022 Apr; 38():32-39. PubMed ID: 35495282
[TBL] [Abstract][Full Text] [Related]
10. Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-naïve Population.
Fredsøe J; Sandahl M; Vedsted P; Jensen JB; Ulhøi BP; Borre M; Sørensen KD; Pedersen BG;
Eur Urol Oncol; 2023 Oct; 6(5):484-492. PubMed ID: 37537016
[TBL] [Abstract][Full Text] [Related]
11. The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort.
Möller A; Olsson H; Grönberg H; Eklund M; Aly M; Nordström T
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):137-142. PubMed ID: 30171228
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study.
Hao S; Heintz E; Östensson E; Discacciati A; Jäderling F; Grönberg H; Eklund M; Nordström T; Clements MS
Eur Urol; 2022 Jul; 82(1):12-19. PubMed ID: 35094896
[TBL] [Abstract][Full Text] [Related]
13. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; Roemeling S; Schröder FH
Eur Urol; 2008 Sep; 54(3):581-8. PubMed ID: 18423977
[TBL] [Abstract][Full Text] [Related]
14. Prostate Biopsies Can Be Omitted in Most Patients with a Positive Stockholm3 Test and Negative Prostate Magnetic Resonance Imaging.
Vinje CA; Vigmostad MN; Kjosavik SR; Grönberg H; Gilje B; Skeie S
Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37805292
[TBL] [Abstract][Full Text] [Related]
15. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
[TBL] [Abstract][Full Text] [Related]
16. Prospective Multicenter Validation of the Stockholm3 Test in a Central European Cohort.
Elyan A; Saba K; Sigle A; Wetterauer C; Engesser C; Püschel H; Attianese S; Maurer P; Deckart A; Cathomas R; Strebel RT; Gratzke C; Seifert HH; Rentsch CA; Mortezavi A
Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37813730
[TBL] [Abstract][Full Text] [Related]
17. PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
Steuber T; Heidegger I; Kafka M; Roeder MA; Chun F; Preisser F; Palisaar RJ; Hanske J; Budaeus L; Schiess R; Keller T; Semjonow A; Hammerer P; Manka L; Ecke T; Schwentner C; Ohlmann C
Eur Urol Oncol; 2022 Jun; 5(3):321-327. PubMed ID: 33422560
[TBL] [Abstract][Full Text] [Related]
18. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
19. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
20. Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.
Matsukawa A; Yanagisawa T; Bekku K; Kardoust Parizi M; Laukhtina E; Klemm J; Chiujdea S; Mori K; Kimura S; Fazekas T; Miszczyk M; Miki J; Kimura T; Karakiewicz PI; Rajwa P; Shariat SF
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38182488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
